Human Molecular Genetics Advance Access originally published online on July 14, 2004
Human Molecular Genetics 2004 13(18):2011-2018; doi:10.1093/hmg/ddh214
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, Vol. 13, No. 18 © Oxford University Press 2004; all rights reserved
Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 77 Louis Pasteur Avenue, Room 630, Boston, MA 02115, USA
Received April 26, 2004; Accepted July 6, 2004
Most human neurodegenerative diseases have a number of common features, including adult onset, progressive degeneration of selected neuronal populations and formation of abnormal protein aggregates. Although these shared characteristics raise the possibility of conserved pathogenic mechanisms, the diverse clinical and pathological features of each disorder indicate significant differences. As a number of human neurodegenerative diseases have now been modeled in Drosophila, and genetic modifiers identified, we have been able to perform a genetic comparison of pathways controlling toxicity in these models. By directly comparing modifiers isolated in the models of polyglutamine diseases and in a Drosophila model of tauopathy, we find a final common pathway of cell death involving apoptosis. Among the polyglutamine diseases, protein folding and histone acetylation are common key mediators. In addition, two novel modifiers suggest shared pathways of toxicity among all the disorders. Cell-type specificity is a salient feature of all neurodegenerative diseases; however, most work to date in the Drosophila models have been performed in the retina. Therefore, we determined whether similar pathways of toxicity operate in neurons of the Drosophila brain. Many, but not all, retinal modifiers also modify toxicity in postmitotic neurons in the brain. Analysis of polyglutamine toxicity in the adult brain facilitated the identification of nicotinamide (vitamin B3), a vitamin with histone deacetylase inhibiting activity, as a potent suppressor of polyglutamine toxicity. These findings outline common pathways of neurotoxicity, demonstrate disease- and cell-type specific pathways and identify a common vitamin as a potential therapy in polyglutamine disorders.
* To whom correspondence should be addressed. Tel: +1 6175254405; Fax: +1 6175254422; Email: mel_feany{at}hms.harvard.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Chatterjee, T.-K. Sang, G. M. Lawless, and G. R. Jackson Dissociation of tau toxicity and phosphorylation: role of GSK-3{beta}, MARK and Cdk5 in a Drosophila model Hum. Mol. Genet., January 1, 2009; 18(1): 164 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pallos, L. Bodai, T. Lukacsovich, J. M. Purcell, J. S. Steffan, L. M. Thompson, and J. L. Marsh Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease Hum. Mol. Genet., December 1, 2008; 17(23): 3767 - 3775. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Green, J. S. Steffan, H. Martinez-Coria, X. Sun, S. S. Schreiber, L. M. Thompson, and F. M. LaFerla Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau J. Neurosci., November 5, 2008; 28(45): 11500 - 11510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Lievens, M. Iche, M. Laval, C. Faivre-Sarrailh, and S. Birman AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease Hum. Mol. Genet., March 15, 2008; 17(6): 882 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Branco, I. Al-Ramahi, L. Ukani, A. M. Perez, P. Fernandez-Funez, D. Rincon-Limas, and J. Botas Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases Hum. Mol. Genet., February 1, 2008; 17(3): 376 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Latouche, C. Lasbleiz, E. Martin, V. Monnier, T. Debeir, A. Mouatt-Prigent, M.-P. Muriel, L. Morel, M. Ruberg, A. Brice, et al. A Conditional Pan-Neuronal Drosophila Model of Spinocerebellar Ataxia 7 with a Reversible Adult Phenotype Suitable for Identifying Modifier Genes J. Neurosci., March 7, 2007; 27(10): 2483 - 2492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zheng, S. W. Edelman, G. Tharmarajah, D. W. Walker, S. D. Pletcher, and L. Seroude Differential patterns of apoptosis in response to aging in Drosophila PNAS, August 23, 2005; 102(34): 12083 - 12088. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Helmlinger, J. Bonnet, J.-L. Mandel, Y. Trottier, and D. Devys Hsp70 and Hsp40 Chaperones Do Not Modulate Retinal Phenotype in SCA7 Mice J. Biol. Chem., December 31, 2004; 279(53): 55969 - 55977. [Abstract] [Full Text] [PDF] |
||||



